Natural products of relevance in the management of attention deficit hyperactivity disorder

Derleme MakaleYayıncıda açık erişimScopus SJRQ1

Özet

Attention deficit hyperactivity disorder (ADHD) is among the most common neurodevelopmental disorders characterized by motor hyperactivity, attention deficit, distraction, impulsive behavior, and relationship difficulties. It affects children, and thus over the years, there has been growing attention on the use of natural product formulations and their naturally-occurring bioactive for overcoming the problem of ADHD. Concerning this issue, this review aims to discuss the ADHD treatment potential of natural products/formulations in vitro, in vivo as well as in clinical trials. To gather the most relevant data regarding bioactive compounds with potential therapeutic effects in the management of ADHD, the following databases were searched: PubMed/MedLine, ScienceDirect, and Google Scholar for articles in English. Various medicinal plants and their isolated biomolecules have been evaluated in vitro, in vivo, and in clinical trials for their ability to treat ADHD. Most of the analyzed research results showed an improvement of ADHD signs and symptoms in in vivo models, but the molecular mechanisms of action of the bioactive compounds are unclear and incompletely elucidated. Further studies are needed to determine the bioactive compound responsible for health-promoting effects in ADHD. In addition, clinical studies should be performed over longer periods with more participants.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/bayburt/10857Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1002/efd2.57Yayıncı resmi DOI adresi
İndeks kayıtları
Kaydın indeks veri tabanlarındaki sayfası (aktarımda alınan kayıt numarasıyla). Erişim, indeksin kendi koşullarına bağlıdır.
Atıflar
Scopus
11
WoS
10
Her kaynağın kendi saydığı toplam atıf; aktarım ve zenginleştirme sırasında alındı.
Tam Kayıt
AlanDeğerDil
dc.contributor.authorCustódio, Luisa
dc.contributor.authorVizetto-Duarte, Catarina
dc.contributor.authorCebeci, Fatma
dc.contributor.authorÖzçelik, Beraat
dc.contributor.authorSharopov, Farukh
dc.contributor.authorGürer, Eda Sonmez
dc.contributor.authorKumar, Manoj
dc.contributor.authorIriti, Marcello
dc.contributor.authorSharifi-Rad, Javad
dc.contributor.authorCalina, Daniela
dc.date.accessioned2026-10-29T17:19:34.055579735Z
dc.date.available2026-10-29T17:19:34.055579735Z
dc.date.issued2023-02
dc.description.abstractAttention deficit hyperactivity disorder (ADHD) is among the most common neurodevelopmental disorders characterized by motor hyperactivity, attention deficit, distraction, impulsive behavior, and relationship difficulties. It affects children, and thus over the years, there has been growing attention on the use of natural product formulations and their naturally-occurring bioactive for overcoming the problem of ADHD. Concerning this issue, this review aims to discuss the ADHD treatment potential of natural products/formulations in vitro, in vivo as well as in clinical trials. To gather the most relevant data regarding bioactive compounds with potential therapeutic effects in the management of ADHD, the following databases were searched: PubMed/MedLine, ScienceDirect, and Google Scholar for articles in English. Various medicinal plants and their isolated biomolecules have been evaluated in vitro, in vivo, and in clinical trials for their ability to treat ADHD. Most of the analyzed research results showed an improvement of ADHD signs and symptoms in in vivo models, but the molecular mechanisms of action of the bioactive compounds are unclear and incompletely elucidated. Further studies are needed to determine the bioactive compound responsible for health-promoting effects in ADHD. In addition, clinical studies should be performed over longer periods with more participants.
dc.description.sponsorshipFCT Scientific Employment Stimulus [CEECIND/00425/2017]
dc.identifier.articlenumbere57
dc.identifier.doi10.1002/efd2.57
dc.identifier.eissn2666-3066
dc.identifier.issn2666-3066
dc.identifier.issue1
dc.identifier.scopus2-s2.0-85147213223
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/bayburt/10857
dc.identifier.volume4
dc.identifier.wosWOS:001191742300001
dc.language.isoen
dc.publisherWILEY
dc.relation.ispartofEFOOD
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectADHD
dc.subjectclinical studies
dc.subjectnatural products
dc.subjectpharmacotherapeutic management
dc.subjectpreclinical studies
dc.subject.classificationFood Science & Technology
dc.subject.otherST-JOHNS-WORT
dc.subject.otherSPONTANEOUSLY HYPERTENSIVE-RAT
dc.subject.otherKOREAN RED GINSENG
dc.subject.otherDEFICIT/HYPERACTIVITY DISORDER
dc.subject.otherRHODIOLA-ROSEA
dc.subject.otherGINKGO-BILOBA
dc.subject.otherDOUBLE-BLIND
dc.subject.otherSCUTELLARIA-BAICALENSIS
dc.subject.otherCHILDREN
dc.subject.otherEXTRACT
dc.titleNatural products of relevance in the management of attention deficit hyperactivity disorder
dc.typeReview Article
rdl.citation.scopus11
rdl.citation.wos10
rdl.oa.statusgold
rdl.scopus.quartileQ1
rdl.source.indexWOS
rdl.source.indexSCOPUS
rdl.wos.indexEmerging Sources Citation Index (ESCI)